BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2892259)

  • 1. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
    Cerulli MA; Cloud ML; Offen WW; Chernish SM; Matsumoto C
    Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study.
    Hentschel E; Schütze K; Reichel W; Kerstan E; Kratochvil P; Brandstätter G; Judmaier G; Keohane PP
    Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing and recurrence of active duodenal ulcer with nizatidine.
    Cloud ML; Offen WW; Matsumoto C; Chernish SM
    Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of duodenal ulceration in the United States.
    Dyck WP; Cloud ML; Offen WW; Matsumoto C; Chernish SM
    Scand J Gastroenterol Suppl; 1987; 136():47-55. PubMed ID: 2892255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
    Cherner JA; Cloud ML; Offen WW; Latz JE
    Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
    Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C
    Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
    Texter EC; Navab F; Mantell G; Berman R
    Am J Med; 1986 Oct; 81(4B):25-32. PubMed ID: 2877571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
    Bovero E; Poletti M; Boero A; Mura BC; Camarri E; Corradini P; Corsini G; Federici G; Curzio M; Gianquinto G
    Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
    Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
    Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
    Pace F; Colombo E; Ferrara A; Prada A; Rocca F; Bianchi Porro G
    Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of nizatidine in clinical trials conducted in the USA and Europe.
    Cloud ML
    Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH; Brogden RN
    Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
    Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
    Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cigarette smoking on recurrence of duodenal ulcer.
    Sumii K; Kimura M; Morikawa A; Haruma K; Yoshihara M; Teshima H; Kajiyama G
    Jpn J Med; 1989; 28(4):492-5. PubMed ID: 2572714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nizatidine].
    Romero M; Franzosi MG
    Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nizatidine (AXID).
    Med Lett Drugs Ther; 1988 Aug; 30(772):77-8. PubMed ID: 2899835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.